Efficacy of magnesium sulphate versus precurarisation dose of vecuronium in attenuating succinylcholine induced fasciculations and post operative myalgia.

Comparison of magnesium sulphate versus precurarisation dose of vecuronium in attenuating succinylcholine induced fasciculations and post operative myalgia. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069311

Enrollment

Registered

2024-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Magnesiumsulphate: Group 1- titrated dose of magnesium sulphate in attenuating succinylcholine induced fasciculations. Group 2- titrated dose of vecuronium in attenuating succinylcholin

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient posted for elective surgey. 2. American Society of Anesthesiologist (ASA)l/ll

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women. 2. Seizure disorder patients. 3. Deranged LFT, KFT 4. Patients with muscular dystrophies. 5. Patients with head trauma, post burn hyperkalemia.

Design outcomes

Primary

Measure	Time frame
Attenuation of succinylcholine induced fasciculations.Timepoint: Intraoperative	—

Secondary

Measure	Time frame
Attenuation of succinylcholine induced post operative myalgia.Timepoint: 24 hours post Surgery	—

Countries

India

Contacts

Public ContactSudeshna Chaudhury

Kalinga Institute of Medical Science

2387001@kims.ac.in7005292628

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026